Saltar al contenido
Merck

Novel H3 receptor antagonists with improved pharmacokinetic profiles.

Bioorganic & medicinal chemistry letters (2008-06-17)
Vincent J Santora, Jonathan A Covel, Rena Hayashi, Brian J Hofilena, Jason B Ibarra, Michelle D Pulley, Michael I Weinhouse, Graeme Semple, Albert Ren, Guilherme Pereira, Jeffrey E Edwards, Marissa Suarez, John Frazer, William Thomsen, Erin Hauser, Jodie Lorea, Andrew J Grottick
RESUMEN

A new series of H(3) antagonists derived from the natural product Conessine are presented. Several compounds from these new series retain the potency and selectivity of earlier diamine based analogs while exhibiting improved PK characteristics. One compound (3u) demonstrated functional antagonism of the H(3) receptor in an in vivo pharmacological model.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Conessine, ≥97% (HPLC)